JP2006512398A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006512398A5 JP2006512398A5 JP2004565744A JP2004565744A JP2006512398A5 JP 2006512398 A5 JP2006512398 A5 JP 2006512398A5 JP 2004565744 A JP2004565744 A JP 2004565744A JP 2004565744 A JP2004565744 A JP 2004565744A JP 2006512398 A5 JP2006512398 A5 JP 2006512398A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- bladder
- transduction enhancer
- luminal surface
- transduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/327,869 US7459154B2 (en) | 2002-12-26 | 2002-12-26 | Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| PCT/US2003/041379 WO2004060303A2 (en) | 2002-12-26 | 2003-12-24 | Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006512398A JP2006512398A (ja) | 2006-04-13 |
| JP2006512398A5 true JP2006512398A5 (enExample) | 2007-02-15 |
Family
ID=32680762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004565744A Withdrawn JP2006512398A (ja) | 2002-12-26 | 2003-12-24 | 膀胱上皮内へのウイルスの形質導入の増強のための方法および試薬 |
Country Status (9)
| Country | Link |
|---|---|
| US (7) | US7459154B2 (enExample) |
| EP (1) | EP1583502A4 (enExample) |
| JP (1) | JP2006512398A (enExample) |
| KR (1) | KR20050088231A (enExample) |
| CN (1) | CN1753618A (enExample) |
| AU (1) | AU2003299972C1 (enExample) |
| CA (1) | CA2510903A1 (enExample) |
| NZ (1) | NZ540732A (enExample) |
| WO (1) | WO2004060303A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7459154B2 (en) * | 2002-12-26 | 2008-12-02 | Cell Genesys, Inc. | Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| US20050059613A1 (en) * | 2003-07-08 | 2005-03-17 | Bahram Memarzadeh | Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium |
| KR20070121644A (ko) * | 2005-01-14 | 2007-12-27 | 유리젠, 인코포레이티드 | 하부 요로 치료용 키트 및 개선된 조성물 |
| ES2564518T3 (es) | 2006-09-14 | 2016-03-23 | Bahram Memarzadeh | Monolaurato de sucralosa y monomiristato de sucralosa, formulaciones farmacéuticas, estuches de diagnóstico y métodos de tratamiento |
| US20110086005A1 (en) * | 2008-05-27 | 2011-04-14 | Oncolytics Biotech Inc. | Modulating interstitial pressure and oncolytic viral delivery and distribution |
| US20130052165A1 (en) * | 2010-01-12 | 2013-02-28 | Livnat Bangio | Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby |
| DE102011085501A1 (de) * | 2011-10-31 | 2013-05-02 | Söring GmbH | Elektrochirurgievorrichtung |
| JP6954648B2 (ja) * | 2015-10-19 | 2021-10-27 | シージー オンコロジー， インコーポレイテッド | 併用療法による固形腫瘍又はリンパ系腫瘍の治療方法 |
| US11497781B2 (en) * | 2016-03-10 | 2022-11-15 | Cg Oncology, Inc. | Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor |
| EP3610026B1 (en) | 2017-04-14 | 2025-05-14 | CG Oncology, Inc. | Cg0070 for treating bcg resistant bladder carcinoma in situ |
| WO2020143221A1 (zh) * | 2019-01-07 | 2020-07-16 | 四川安可康生物医药有限公司 | 增强系统免疫应答的免疫溶瘤病毒组合药物及其应用 |
| EP4175969A4 (en) * | 2020-07-01 | 2024-07-24 | Medimmune, LLC | DETERGENT AND METHOD FOR PURIFYING A BIOTHERAPY AGENT |
| CN113717953B (zh) * | 2021-08-05 | 2024-07-26 | 北京舜雷科技有限公司 | 一种减毒黄病属病毒在溶瘤中的应用 |
| WO2025251009A1 (en) * | 2024-05-31 | 2025-12-04 | Cg Oncology, Inc. | Methods of treating bladder cancer using an oncolytic virus and a transduction-enhancing agent |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US169138A (en) * | 1875-10-26 | Improvement in folding lounges | ||
| JPH01245159A (ja) * | 1988-03-28 | 1989-09-29 | Gen Corp:Kk | ニューカッスル病ウィルス抗体の検出用プレート及び抗原ウィルスの可溶化方法 |
| US5369095A (en) | 1990-02-14 | 1994-11-29 | Alcon Laboratories, Inc. | Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers |
| US6165500A (en) * | 1990-08-24 | 2000-12-26 | Idea Ag | Preparation for the application of agents in mini-droplets |
| US5525519A (en) * | 1992-01-07 | 1996-06-11 | Middlesex Sciences, Inc. | Method for isolating biomolecules from a biological sample with linear polymers |
| US5368844A (en) | 1992-12-16 | 1994-11-29 | Colgate Palmolive Company | Antiplaque, antigingivitis, anticaries oral composition |
| JPH11502233A (ja) * | 1995-12-08 | 1999-02-23 | 花王株式会社 | 殺菌剤組成物 |
| US5789244A (en) | 1996-01-08 | 1998-08-04 | Canji, Inc. | Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems |
| US20020169138A1 (en) * | 1997-10-24 | 2002-11-14 | Southern Research Institute | Delivery vehicles for bioactive agents and uses thereof |
| US6855549B1 (en) * | 1998-11-23 | 2005-02-15 | The University Of Iowa Research Foundation | Methods and compositions for increasing the infectivity of gene transfer vectors |
| ATE419338T1 (de) | 2000-03-24 | 2009-01-15 | Cell Genesys Inc | Menschliche zellspezifische urotheliale regulatorische sequenzen der transkription des uroplakins, dessen vektoren und verwendungsverfahren |
| US6911200B2 (en) | 2000-03-24 | 2005-06-28 | Cell Genesys, Inc. | Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation |
| IL139708A0 (en) * | 2000-11-15 | 2002-02-10 | Amiel Gilad | Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering |
| AUPR894201A0 (en) * | 2001-11-19 | 2001-12-13 | Women's And Children's Hospital | Respiratory delivery for gene therapy and lentiviral delivery particle |
| US7459154B2 (en) * | 2002-12-26 | 2008-12-02 | Cell Genesys, Inc. | Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
-
2002
- 2002-12-26 US US10/327,869 patent/US7459154B2/en not_active Expired - Lifetime
-
2003
- 2003-12-24 EP EP03800237A patent/EP1583502A4/en not_active Withdrawn
- 2003-12-24 AU AU2003299972A patent/AU2003299972C1/en not_active Expired
- 2003-12-24 NZ NZ540732A patent/NZ540732A/en not_active IP Right Cessation
- 2003-12-24 US US10/743,813 patent/US7267815B2/en not_active Expired - Lifetime
- 2003-12-24 KR KR1020057012091A patent/KR20050088231A/ko not_active Withdrawn
- 2003-12-24 JP JP2004565744A patent/JP2006512398A/ja not_active Withdrawn
- 2003-12-24 CA CA002510903A patent/CA2510903A1/en not_active Abandoned
- 2003-12-24 CN CNA2003801076205A patent/CN1753618A/zh active Pending
- 2003-12-24 WO PCT/US2003/041379 patent/WO2004060303A2/en not_active Ceased
-
2007
- 2007-08-29 US US11/897,535 patent/US20080138322A1/en not_active Abandoned
- 2007-10-25 US US11/978,112 patent/US20080241105A1/en not_active Abandoned
- 2007-10-25 US US11/977,943 patent/US20080112932A1/en not_active Abandoned
- 2007-10-25 US US11/977,781 patent/US20080112931A1/en not_active Abandoned
-
2008
- 2008-09-23 US US12/284,734 patent/US20090068151A1/en not_active Abandoned